"Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial"
doi: 10.1530/edm-21-0007
Clinical Study VGX-001-012 VGX-001-012 was a single-blind multicenter, Phase 2, randomized, placebo-controlled, ascending dose, crossover study
Legal risks Purchasing and using substances not approved for human consumption can expose you to legal liabilities
Effects of semaglutide with or without concomitant mineralocorticoid receptor antagonist use in participants with type 2 diabetes and chronic kidney disease: a FLOW trial prespecified secondary analysis
Tirzepatide: Dual Agonist with Long-Lasting Impact Tirzepatide takes things one step further by acting as a dual agonist of both GLP-1 and GIP receptors